2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Persistent Corneal Epithelial Defect: new trials by email Literature Review of Persistent Corneal Epithelial Defect trials Research Report on Persistent Corneal Epithelial Defect
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED KPI-012, KPI-012 Vehicle - Persistent Corneal Epithelial Defect | Phase 2 | Terminated | Combangio, Inc | 103 | 2023-02-07 | 2025-10-22 |
| ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects ST266, 0.67% Sodium Chloride Ophthalmic Solution, Open-label ST266 - Persistent Corneal Epithelial Defect | Phase 2 | Terminated | Noveome Biotherapeutics, formerly Stemnion | 8 | 2022-04-27 | 2022-10-25 |
Combangio, Inc (1) · Noveome Biotherapeutics, formerly Stemnion (1)
United States (2) · Argentina (1) · Puerto Rico (1)
Kristie Veasey (1)